We believe this is budgetarily responsible as well.

I believe that that would be the worst thing we could do. I believe it would stifle innovation.

The incident involving Cambridge Analytica and the compromised personal information of approximately 87 million American users--or mostly American users--is deeply disturbing to this committee.

Does Congress need to clarify whether or not consumers own or have any real power over their online data?

This committee has already been instrumental in working in a bipartisan manner to devote a record--let me underscore record--amount of Federal resources toward the opioid epidemic.

We must continue to push forward. And I would respectfully ask everyone involved, stakeholders and Members of Congress alike, to push beyond our comfort zones and think creatively and boldly about how we can help.

While Facebook has certainly grown, I worry it may not have matured.

We look forward to continuing our work with them to get a robust bipartisan package of proposals to the White House for signature of the President in the coming months.

We can and must advance opioid legislation in a bipartisan manner that the American people deserve.

President Trump rightly called it the crisis next door, and earlier this week, rolled out an ambitious plan.

The goal is then to get to good public policy and try and help people back home.

We stand ready to work with the President and his administration to put a stop to this crisis once and for all.

The unprecedented plague of opioid addiction and substance use disorder in our country requires an unprecedented response.

This epidemic knows no geographic, no political, nor any socioeconomic bounds.

Today marks the second of three legislative hearings advancing collaborative bipartisan legislative solutions to help combat the opioid crisis.

You raise an interesting issue about the U.S. attorneys weighing in here and saying to the DEA, stop--don't do your ISO--we want to proceed with the criminal investigation.

There's enormous potential with the development of small-scale modular reactors including from my home State of Oregon in NuScale.

For nearly a year, this committee has been investigating how inordinate numbers of pills were shipped to pharmacies in rural West Virginia.

I now have the honor of yielding 3 minutes to the gentleman from Pennsylvania (Mr. Fitzpatrick), who has been, even before he got to the Congress, an extraordinary advocate for this cause and for the patients with terminally ill conditions.

So at the end of the day, if we focus on what's best for consumers we will continue to make good public policy decisions.

When Illinois took this up, they approved it 169-1 in their assembly. Mr. Speaker, I yield as much time as he may consume to the gentleman from Virginia (Mr. Griffith).

We are looking ahead to make sure we are doing everything we can to protect our electric grid and our oil and natural gas infrastructure as well and improve our ability to respond when the unexpected happens.

May I inquire as to how much time remains for each side. The SPEAKER pro tempore (Mr. Weber of Texas). The gentleman from Oregon has 3 minutes remaining. The gentleman from New Jersey has 1 minute remaining.

I yield 2 minutes to the gentleman from Georgia (Mr. Carter), a distinguished member of our committee and a pharmacist by training and trade.

We have a history of producing bipartisan user fee reauthorizations, most recently as last year, and so I look forward to continuing in those efforts with this one.